Flex (FLEX) Q1 2026 Earnings Call July 24, 2025 08:30 AM ET Company ParticipantsMichelle Simmons - SVP - Investor & Public RelationsRevathi Advaithi - CEO & DirectorKevin Krumm - CFOMark Delaney - US Autos & Industrial TechSteven Fox - Founder & CEORuplu Bhattacharya - DirectorSteve Barger - Managing Director - Equity ResearchConference Call ParticipantsSamik Chatterjee - MD & Equity Research AnalystOperatorThank you for standing by. Welcome to Flex's First Quarter Fiscal twenty twenty six Earnings Conferen ...

Flex (FLEX) Q1 2026 Earnings Call July 24, 2025 08:30 AM ET Speaker0Thank you for standing by. Welcome to Flex's First Quarter Fiscal twenty twenty six Earnings Conference Call. Presently, all participants are in a listen only mode. After the speakers' remarks, there will be a question and answer session. As a reminder, this call is being recorded.I will now turn the call over to Ms. Michelle Simmons. You may begin.Speaker1Thank you. Good morning, and thank you for joining us today for Flex's first quarter ...

Group 1 - Flex will announce its first quarter fiscal 2026 financial results on July 24, 2025, before the market opens [1] - A conference call to discuss the results will take place on the same day at 7:30 AM (CT) / 8:30 AM (ET) [1] - The live webcast presentation will be available on the Flex Investor Relations website [2] Group 2 - Flex is a manufacturing partner that helps a diverse customer base design and build products [3] - The company operates in 30 countries and focuses on responsible, sustainable operations [3] - Flex delivers technology innovation, supply chain, and manufacturing solutions to various industries and end markets [3]

Core Insights - Celestica, Inc. (CLS) reported a 20% year-over-year revenue increase to $2.64 billion in Q1 2025, driven by strong performance in the Connectivity & Cloud Solutions segment [1] - The company anticipates a revenue of $10.91 billion in 2025, reflecting a 13.15% year-over-year growth, supported by demand in the AI-data center infrastructure market [3] Group 1: Company Performance - CLS experienced significant growth in its High Performance Solutions product lines, with revenues up 99% year-over-year, primarily due to strong sales of 400G and 800G switches [1] - The introduction of innovative products like the ES1500 enterprise access switch and the DS4100 800G switch is enhancing CLS's market position [2] - Celestica's stock has increased by 165.5% over the past year, outperforming the industry growth of 94.7% [7] Group 2: Competitive Landscape - Celestica faces competition from Sanmina Corporation and Jabil, Inc. in the electronics contract manufacturing services sector [4] - Sanmina reported $1.59 billion in revenues for Q2 2025, marking a 9.7% year-over-year growth, with a projected revenue of $8.1 billion for 2025 [5] - Jabil's Intelligent Infrastructure segment generated $3.4 billion in revenues, up 51% year-over-year, with an expected revenue of $29.05 billion for the current fiscal year [6] Group 3: Valuation and Estimates - Celestica's forward price-to-earnings ratio stands at 27.47, which is above the industry average [8] - The Zacks Consensus Estimate for Celestica's earnings for 2025 has remained unchanged over the past 60 days [9]

Financial Data and Key Metrics Changes - The company reported a compound annual growth rate (CAGR) of 16% in revenue and 21% in earnings over the past ten years, indicating strong growth compared to the contract manufacturing industry [9][105] - For fiscal year 2025, the company expects revenue to be up approximately 18% compared to fiscal year 2024 [9] Business Line Data and Key Metrics Changes - The optical communications segment accounts for over 70% of the company's business, with datacom and telecom roughly split [6] - The datacom business has been growing well, while the telecom business has recently shown strength [6] - The gross margin has been in the range of 12% to 13%, with operating margins around 10% to 11% [13][14] Market Data and Key Metrics Changes - The company has seen a significant increase in demand for 400 ZR products, which now represent about 10% of overall revenue [72] - The telecom revenue has rebounded to approximately $406 million, recovering from a previous low due to inventory digestion [70][71] Company Strategy and Development Direction - The company focuses on being a pure play contract manufacturer without its own products, which allows it to maintain strong relationships with customers [8][96] - The strategy includes expanding capabilities in optical subsystems and components while maintaining low costs and high margins [14][17] - The company is also exploring opportunities in co-packaged optics, which is expected to be additive to existing business [60] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the stability of the macro environment, noting that the products manufactured are primarily for infrastructure projects, which are less susceptible to consumer sentiment [24] - The company is closely monitoring tariff impacts but has not seen significant effects on operations [25] - Management believes that the telecom business will continue to grow, driven by system wins and the recovery of baseline business [80] Other Important Information - The company has a layered hedge structure for foreign exchange risks, primarily related to the Thai baht [101] - The tax rate is expected to remain stable, with no significant increases anticipated [82] Q&A Session Summary Question: What makes Fabrinet unique versus others? - The company emphasizes its specialization in a few key areas, maintaining a strong reputation and executing well for customers, which builds trust and leads to more business [94][96] Question: How do you expect your tax rate to change? - The company operates at a mid-single-digit tax rate and expects to maintain this due to ongoing tax benefits in Thailand [82] Question: Can you elaborate on the systems wins with Cisco, Sienna, and Amazon? - The company has secured significant wins with Cisco and Sienna, and is optimistic about the relationship with Amazon, which spans multiple revenue categories [84][48] Question: What is the current state of inventory levels across the industry? - Inventory levels are improving but have not returned to pre-COVID levels; the company is seeing a downward trend in customer inventory [88][87] Question: How does the company maintain its margin structure? - The company focuses on controlling costs and maintaining a stable margin structure despite short-term headwinds from product ramps [104]

Market Overview - The Asia-Pacific Pharmaceutical Contract Manufacturing Organization (CMO) Market is projected to grow from an estimated USD 59.97 billion in 2025 to USD 91.18 billion by 2030, reflecting a compound annual growth rate (CAGR) of 8.74% [2] - The market landscape is highly fragmented, with large pharmaceutical firms increasingly outsourcing production to CMOs for cost efficiency and expertise [6] Regional Insights - China's competitive advantage in the CMO market is attributed to low labor costs, tax incentives, and favorable currency valuation, which help reduce manufacturing expenses [3] - India is attracting Japanese pharmaceutical investments through favorable foreign direct investment policies, enhancing its domestic manufacturing landscape [8] - Japan's CMO sector has experienced a 30% growth due to regulatory changes that separate manufacturing from sales [8] - Australia faces challenges due to pricing and reimbursement volatility but benefits from its geographical proximity to South Asian markets [8] Market Dynamics - The demand for injectable drugs, particularly for rapid-acting oncology treatments, presents significant growth opportunities within the market [8] - Prolific late-stage clinical trials, especially in cancer therapies, are expected to drive market growth, with anti-cancer drugs making up nearly half of the developmental pipeline [8] - Outsourcing of biologic formulations to CMOs is common as major pharmaceutical companies focus on discovering and developing new drug modalities [8] Industry Developments - Recent expansions by companies such as Jubilant Biosys in India and Boehringer's capacity increase in China highlight strategic collaborations aimed at enhancing market share [6] - New policies in India allowing certain drug studies without late-stage clinical trials lead to considerable cost savings, further strengthening its appeal for pharmaceutical production [8] Challenges - The COVID-19 pandemic has disrupted global supply chains, necessitating strategic responses to inventory management, particularly as China is a key supplier of essential raw materials [8] - Increasing lead times and logistics costs, along with stringent regulatory requirements, pose challenges for the CMO market [14]

Financial Data and Key Metrics Changes - Net sales for Q1 2025 totaled $26.9 million, a decrease of 21.4% from $34.2 million in Q1 2024, impacted by delays in customer approvals and manufacturing efficiencies [15][16] - Gross profit for Q1 2025 was $3.1 million, or 11.1% of net sales, compared to $5.4 million, or 15.9% in the same quarter last year, due to lower sales and reduced facility utilization [16] - Adjusted EBITDA for Q1 2025 was negative $1 million, down from $1.6 million in Q1 2024, reflecting ongoing operational challenges [18] Business Line Data and Key Metrics Changes - The aerospace and defense segment faced revenue impacts due to the closure of the Blue Earth facility and delays in customer approvals for the transfer of programs to the Bemidji facility [4][5] - Customer backlog has stabilized as of March 31, 2025, consistent with the year-end 2024 backlog, with expectations for improved order volume as approvals are completed [16] Market Data and Key Metrics Changes - The company is closely monitoring supply chain strategies as customers evaluate their operations in light of tariff uncertainties, particularly regarding facilities in China and Mexico [6][7] - Opportunities are emerging in China as companies seek to consolidate manufacturing within the region, aligning with the company's nearshoring strategy [7] Company Strategy and Development Direction - The company is focused on reducing operating costs and aligning operations with market demand to drive sustainable long-term EBITDA growth [21] - A three-tier global manufacturing strategy across the US, Mexico, and China is in place to enhance competitiveness and operational flexibility [10][11] - The company is investing in engineering expertise and product innovation, particularly in fiber optic technologies, to meet evolving customer needs [24][26] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the stabilization of customer backlogs and the potential for revenue recovery in the second half of 2025 [5][9] - The company is committed to monitoring geopolitical uncertainties and adjusting strategies to mitigate risks associated with tariffs and supply chain disruptions [6][7] Other Important Information - The company plans to further reduce inventory investments throughout 2025, aiming to improve cash flow and operational efficiency [19][21] - The focus on sustainability and innovation in fiber optics is expected to align with industry trends and customer demands for environmentally friendly solutions [26][27] Q&A Session Summary Question: What are the expectations for future revenue recovery? - Management expects revenue recovery in the second half of 2025 as customer approvals are completed and operational efficiencies improve [5][9] Question: How is the company addressing tariff impacts? - The company is closely monitoring tariff implications and adjusting pricing and sourcing strategies to mitigate adverse effects [7] Question: What innovations are being pursued in product development? - The company is advancing fiber optic technologies, including EBX and AOX, to enhance product performance and meet customer needs [24][26]

ab 14 May 2025 Global Research Inventec Q125 earnings: Solid results but guiding a fade into 2H25 Q125 reports solid profitability from servers Inventec held its Q125 results call after the close May 13th. Sales was NT$157.0bn (- 21% QoQ, +20% YoY), largely in-line with street and UBSe. Mix shifted to notebooks 49%, servers 48%, smart devices 3%, versus 47%, 49% and 4% respectively in Q424. AI servers reached 50% of server sales vs. 25-30% in 2024 mostly still Hopper generation H200 HGX systems and H20 to C ...

Kimball Electronics (KE) Q3 2025 Earnings Call May 07, 2025 10:00 AM ET Company Participants Andrew Regrut - Treasurer & Investor Relations OfficerRichard Phillips - CEOJana Croom - Chief Financial OfficerMike Crawford - SMD & Head of Discovery GroupSteven Korn - COOJaeson Schmidt - Director of Research Conference Call Participants Derek Soderberg - Director, Senior Equity Research AnalystAnja Soderstrom - Senior Equity Research AnalystHendi Susanto - Research Analyst Operator Good morning, ladies and gentl ...

Kimball Electronics (KE) Q3 2025 Earnings Call May 07, 2025 10:00 AM ET Speaker0 Good morning, ladies and gentlemen, and welcome to the Kimball Electronics Third Quarter Fiscal twenty twenty five Earnings Conference Call. My name is Kevin, and I'll be your facilitator for today's call. All lines have been placed in a listen only mode to prevent any background noise. After the completion of the prepared remarks from the Kimball Electronics leadership team, there will be a question and answer session. Today's ...